Joao Andrade, Chief Executive Officer at WideCells Group PLC (LON:WDC) tells Proactive Investors the stem cells services provider is “ideally positioned” to start generating revenues in 2017 from all its three divisions.
Andrade adds that after having listed in London last July they’ve made significant progress in the commercialisation of their stem cell services as well as rolling out their revolutionary stem cell insurance product CellPlan.